WHO ICTRP trial
Vitamin B1 (thiamine) administration in enterally-fed critically ill patients…
ACTRN12619000121167 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12619000121167 |
|---|---|
| Public title | Vitamin B1 (thiamine) administration in enterally-fed critically ill patients with hypophosphatemia: A prospective, randomised clinical trial |
| Scientific title | Effect of exogenous vitamin B1 (thiamine) administration on blood lactate concentrations in enterally-fed, critically ill patients with hypophosphatemia |
| Primary sponsor | Royal Melbourne Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Critical illness;Hypophosphatemia;Thiamine deficiency;enteral nutrition; Critical illness Hypophosphatemia Thiamine deficiency enteral nutrition;Metabolic and Endocrine - Other metabolic disorders;Diet and Nutrition - Other diet and… |
| Interventions | Intervention: Thiamine (200mg every 12 hours) Thiamine (100mg/mL) will be administered intravenously as 200mg in 100mL sodium chloride 0.9% over 30 minutes. Infusions will occur twice daily while participants remain in the ICU, for a… |
| Registration date | Jan 25, 2019 |
| Target size | 90 |
| Secondary IDs | Nil known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: